NCT02789657 2022-05-19
Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.
Brown University
Phase 2 Completed
Brown University
University of Maryland, Baltimore
Washington University School of Medicine
Albert Einstein College of Medicine
Masonic Cancer Center, University of Minnesota
Stanford University